Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients

被引：0
|
作者：
Pawelczyk, T. [1 ]
Pawelczyk, A. [2 ]
Strzelecki, D. [1 ]
Bialkowska, J. [3 ]
Jablkowski, M. [3 ]
Dworniak, D. [3 ]
Rabe-Jablonska, J. [1 ]
机构：
[1] Med Univ Lodz, Dept Affect Psychot Disorders & Adolescent Psychi, Lodz, Poland
[2] SPZOZ PaLMA, Outpatient Psychiat Clin, Lodz, Poland
[3] Med Univ Lodz, Dept Infect Dis, Lodz, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70814-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S526 / S527
页数：2
相关论文
共 50 条
  • [1] Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients
    Pawelczyk, A.
    Pawelczyk, T.
    Rabe-Jablonska, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S74 - S75
  • [2] peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis C (CHC) patients
    Pawelczyk, T.
    Strzelecki, D.
    Pawelczyk, A.
    Rabe-Jablonska, J.
    EUROPEAN PSYCHIATRY, 2007, 22 : S303 - S303
  • [3] Pegylated interferon a and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients
    Pawelczyk, Tomasz
    Pawelczyk, Agnieszka
    Strzelecki, Dominik
    Rabe-Jablonska, Jolanta
    GENERAL HOSPITAL PSYCHIATRY, 2008, 30 (06) : 501 - 508
  • [4] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
  • [5] Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
    Comai, Stefano
    Cavalletto, Luisa
    Chemello, Liliana
    Bernardinello, Elisabetta
    Ragazzi, Eugenio
    Costa, Carlo Virgilio Luigi
    Bertazzo, Antonella
    PHARMACOLOGICAL RESEARCH, 2011, 63 (01) : 85 - 92
  • [6] Acquired endocrine disorders after peg-interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Wang, T-E
    Chen, M-J
    Liou, T-C
    Wang, H-Y
    Chu, C-H
    Chen, C-J
    Hu, K-C
    Shih, S-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A181 - A182
  • [7] THERAPEUTIC RESPONSE TO PEG-INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
    Harja-Alexa, Ioana-Alina
    Luca, Mihaela-Catalina
    Manciuc, Carmen Doina
    Vata, A.
    Badescu, Aida
    Hurmuzache, M. E.
    Ciocan, Alexandra Mirela
    Hunea, Ioana Maria
    Trofin, Felicia
    Iancu, Luminita Smaranda
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (04): : 615 - 622
  • [8] Successful treatment with high dose consensus interferon and ribavirin of patients with chronic hepatitis C who are resistant to PEG-interferon and ribavirin therapy
    Rothstein, Kenneth D.
    Koka, Ramesh
    Fernandez, Angel
    Hargrove, Holly
    Singh, Shailender
    Araya, Victor
    Munoz, Santiago J.
    GASTROENTEROLOGY, 2006, 130 (04) : A286 - A286
  • [9] COULD PEG-INTERFERON AND RIBAVIRIN BE EFFECTIVE AND SAFE IN THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C?
    Madonia, S.
    Barone, R.
    Pantalone, G. Restivo
    Sinagra, E.
    Perricone, G.
    Renda, M. C.
    Piazza, A.
    Maggio, A.
    Cottone, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S351 - S352
  • [10] The effect of statins on PEG-interferon/ribavirin treatment for chronic hepatitis C
    Yen, Roy D.
    Prabhu, Anoop
    Mahl, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S217 - S217
12345